Valuation: ALTEOGEN Inc.

Market Cap 19,336B 12.49B 10.94B 10.09B 9.42B 17.73B 1,183B 18.04B 121B 46.99B 583B 46.95B 45.9B 2,035B P/E 2026 *
66x
P/E 2027 * 44.3x
Enterprise Value 18.84B 12.17M 10.66M 9.83M 9.17M 17.27M 1.15B 17.58M 118M 45.77M 568M 45.74M 44.72M 1.98B EV / Sales 2026 *
40.2x
EV / Sales 2027 * 27.5x
Free-Float
74.26%
Yield 2026 *
0.14%
Yield 2027 * 0.15%
1 day-3.22%
1 week+3.00%
Current month-2.17%
1 month-2.17%
3 months-5.25%
6 months-20.66%
Current year-19.69%
1 week 331,500
Extreme 331500
397,500
1 month 286,000
Extreme 286000
397,500
Current year 286,000
Extreme 286000
529,000
1 year 286,000
Extreme 286000
569,000
3 years 38,000
Extreme 38000
569,000
5 years 27,875
Extreme 27875
569,000
10 years 3,645.83
Extreme 3645.8333
569,000
Manager TitleAgeSince
Chief Executive Officer 60 2025-12-25
Director of Finance/CFO 61 2023-03-27
Corporate Officer/Principal - -
Director TitleAgeSince
Chairman 71 2008-05-12
Director/Board Member 70 2021-03-28
Director/Board Member 61 2023-03-27
Date Insider Type Main position Quantity % Market Cap.
25-05-20Fiscal year

Chief Executive Officer

7,200 0.0135%
24-03-26Sell 1,600,000 3.0182%
24-01-04Sell 6,000 0.0115%
Change 5-day change 1-year change 3-year change Capi.($)
-3.22%+3.00%-5.12%+762.60% 12.95B
-1.31%+1.80%+19.68%-11.98% 64.28B
-0.57%+5.82%+53.94%+227.66% 57.29B
-3.94%+39.10%+39.10%+39.10% 43.45B
-0.56%+1.65%-51.04%-58.77% 38.02B
-0.26%+8.19%+71.37%-23.42% 31.98B
+0.47%+18.00%+157.84%-42.65% 27.66B
-1.13%+9.36%+65.80%+83.28% 22.91B
-0.56%+5.64%+2.91%+174.96% 17.74B
-0.13%+3.87%+62.33%+122.76% 16.45B
Average -1.21%+6.14%+41.68%+127.35% 33.27B
Weighted average by Cap. -1.23%+5.80%+39.91%+80.29%

Financials

2026 *2027 *
Net sales 469B 303M 265M 245M 228M 430M 28.68B 437M 2.94B 1.14B 14.14B 1.14B 1.11B 49.33B 672B 434M 380M 351M 327M 616M 41.12B 627M 4.21B 1.63B 20.27B 1.63B 1.6B 70.74B
Net income 311B 201M 176M 162M 151M 285M 19.01B 290M 1.95B 755M 9.37B 754M 738M 32.7B 397B 256M 224M 207M 193M 364M 24.26B 370M 2.48B 964M 11.96B 963M 941M 41.74B
Net Debt -499B -322M -282M -260M -243M -457M -30.52B -465M -3.12B -1.21B -15.04B -1.21B -1.18B -52.5B -828B -535M -468M -432M -403M -759M -50.63B -772M -5.18B -2.01B -24.96B -2.01B -1.96B -87.1B
Logo ALTEOGEN Inc.
Alteogen Inc is a Korea-based company primarily engaged in the research, development, and sales of biopharmaceuticals. The Company develops, produces, and sells biopharmaceuticals, including biobetters and novel biopharmaceuticals, based primarily on hyaluronidase protein engineering technology, sustained-release biopharmaceutical technology, and next-generation antibody-drug conjugate technology. In addition, the Company is engaged in research, development, and commercialization of biosimilars.
Employees
172
Date Price Change Volume
26-06-30 ₩361,000.00 -3.22% 432,302
26-06-29 ₩373,000.00 +8.59% 686,307
26-06-26 ₩343,500.00 -8.40% 564,203
26-06-25 ₩375,000.00 +0.94% 864,906
26-06-24 ₩371,500.00 +11.56% 817,479
Trader
Investor
Global
Quality
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
361,000.00KRW
Average target price
458,000.00KRW
Spread / Average Target
+26.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A196170 Stock